Effectiveness of switching from nalfurafine to difelikefalin in patients with hemodialysis-associated pruritus: a prospective interventional study within a new treatment algorithm

Abstract Background Since June 2009, our facility has been using an internally developed treatment algorithm that facilitates a comprehensive approach to address each cause of hemodialysis-associated pruritus (HAP), wherein oral nalfurafine, a selective κ-opioid receptor (KOR) agonist, is used for p...

Full description

Saved in:
Bibliographic Details
Main Authors: Naoko Takahashi, Taku Yoshizawa, Junko Kumagai, Hideki Kawanishi, Shinichiro Tsuchiya, Misaki Moriishi, Takao Masaki
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Renal Replacement Therapy
Subjects:
Online Access:https://doi.org/10.1186/s41100-025-00653-4
Tags: Add Tag
No Tags, Be the first to tag this record!